 <h1>Measles virus vaccine / mumps virus vaccine / rubella virus vaccine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to measles virus vaccine / mumps virus vaccine / rubella virus vaccine: powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, measles virus vaccine/mumps virus vaccine/rubella virus vaccine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking measles virus vaccine / mumps virus vaccine / rubella virus vaccine:</p><p>
<i>Symptoms of allergic reaction</i>
</p><ul>
<li>Difficulty in breathing or swallowing</li>
<li> hives</li>
<li>itching, especially of feet or hands</li>
<li>reddening of skin, especially around ears</li>
<li> swelling of eyes, face, or inside of nose</li>
<li>unusual tiredness or weakness (sudden and severe)</li>
</ul><p>Check with your doctor as soon as possible if any of the following side effects occur while taking measles virus vaccine / mumps virus vaccine / rubella virus vaccine:</p><p>
<i>More common</i>
</p><ul>
<li>Fever higher than 103 °F (39.4 °C)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Pain or tenderness of eyes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bruising or purple spots on skin</li>
<li>confusion </li>
<li>convulsions (seizures)</li>
<li> double vision</li>
<li>headache (severe or continuing)</li>
<li>irritability</li>
<li>pain, numbness, or tingling of hands, arms, legs, or feet</li>
<li>pain, tenderness, or swelling in testicles and scrotum</li>
<li>stiff neck </li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of measles virus vaccine / mumps virus vaccine / rubella virus vaccine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning or stinging at place of injection</li>
<li> fever between 100 and 103 °F (37.7 and 39.4 °C)</li>
<li> skin rash</li>
<li>swelling of glands in neck</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Aches or pain in joints</li>
<li>headache (mild) </li>
<li>itching, swelling, redness, tenderness, or hard lump at place of injection</li>
<li>nausea</li>
<li>runny nose</li>
<li>sore throat</li>
<li>vague feeling of bodily discomfort</li>
</ul><p>The above side effects (especially aches or pain in joints) are more likely to occur in adults, particularly women.</p><p>
<!-- end powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to measles virus vaccine / mumps virus vaccine / rubella virus vaccine: subcutaneous powder for injection</i></p><h3>General</h3><p>The most common adverse events were injection site reactions and fever.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Redness at the injection site, injection site pain, injection site swelling</p>
<p><b>Common</b> (1% to 10%): Injection site bruising, burning and/or stinging at injection site </p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site rash</p>
<p><b>Postmarketing reports</b>: Vesicles at injection site, wheal and flare at injection site<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fever equal to or greater than 38C (rectal) or 37.5C (axillary/oral)</p>
<p><b>Common</b> (1% to 10%): Fever over 39.5C (rectal) or 39C (axillary/oral)</p>
<p><b>Uncommon</b> (0.1% to 1%): Otitis media, injury</p>
<p><b>Rare</b> (less than 0.1%): Death from various and in some cases unknown causes</p>
<p><b>Postmarketing reports</b>: Malaise, peripheral edema, papillitis, swelling, tenderness<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Dizziness</p>
<p><b>Rare</b> (less than 0.1%): Febrile convulsions</p>
<p><b>Postmarketing reports</b>: Encephalitis, cerebellitis, cerebellitis like symptoms (including transient gait disturbance and transient ataxia), Guillain-Barre syndrome, transverse myelitis, peripheral neuritis, subacute sclerosing panencephalitis, afebrile convulsions or seizures, encephalopathy, measles inclusion body encephalitis, paresthesia, polyneuritis, polyneuropathy, optic neuritis, retrobulbar neuritis, syncope<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, pharyngitis, bronchitis, cough, respiratory disorder, rhinitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Nasopharyngitis, rhinorrhea, laryngitis, stridor, epistaxis, sinusitis</p>
<p><b>Rare</b> (less than 0.1%): Pneumonia, pneumonitis</p>
<p><b>Postmarketing reports</b>: Bronchial spasm, sore throat<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Urticaria, dermatitis, eczema, pruritus, herpes simplex, herpes zoster, skin exfoliation, nail disorder</p>
<p><b>Frequency not reported</b>: Panniculitis</p>
<p><b>Postmarketing reports</b>: Erythema multiforme, panniculitis, purpura, skin induration, Stevens-Johnson syndrome, pruritus<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Nervousness</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal crying, insomnia</p>
<p><b>Postmarketing reports</b>: Irritability<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Parotid gland enlargement, vomiting, gastrointestinal disorder, toothache, enteritis, gastroenteritis, stomatitis, stomatitis aphthous, abdominal pain</p>
<p><b>Rare</b> (less than 0.1%): Nausea</p>
<p><b>Frequency not reported</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lymphadenopathy, anemia</p>
<p><b>Rare</b> (less than 0.1%): Thrombocytopenia, thrombocytopenic purpura</p>
<p><b>Frequency not reported</b>: Leukocytosis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Viral infection</p>
<p><b>Frequency not reported</b>: Atypical measles</p>
<p><b>Postmarketing reports</b>: Meningitis, measles-like syndrome, mumps-like syndrome (including orchitis, epididymitis, and parotitis)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Conjunctivitis</p>
<p><b>Postmarketing reports</b>: Ocular palsies, retinitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia</p>
<p><b>Frequency not reported</b>: Diabetes mellitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions</p>
<p><b>Postmarketing reports</b>: Anaphylactic reactions (including related phenomenon such as angioneurotic edema, facial edema, and peripheral edema), anaphylactoid reaction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (less than 0.1%): Vasculitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Epididymitis, orchitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Arthralgia, arthritis, myalgia<sup>[Ref]</sup></p><p>The vaccine has rarely been associated with chronic joint symptoms.  The incidence of arthritis and arthralgia is generally higher in adult women than in children (women, 12% to 26%; children, 0% to 3%), and symptoms tend to be more marked and of longer duration, persisting for months or years (rare).  In adolescent girls, the incidence of reactions appears to be intermediate between those seen in children and in women.  These reactions are generally well tolerated and rarely interfere with normal activities, even in women over 35 years old.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. M-M-R II (measles/mumps/rubella virus vaccine)." Merck &amp; Company Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about measles virus vaccine / mumps virus vaccine / rubella virus vaccine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: vaccine combinations</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>M-M-R II</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Mumps Prophylaxis</li>
<li>Measles Prophylaxis</li>
<li>Rubella Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to measles virus vaccine / mumps virus vaccine / rubella virus vaccine: subcutaneous powder for injection</i></p><h3>General</h3><p>The most common adverse events were injection site reactions and fever.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Redness at the injection site, injection site pain, injection site swelling</p><p><b>Common</b> (1% to 10%): Injection site bruising, burning and/or stinging at injection site </p><p><b>Uncommon</b> (0.1% to 1%): Injection site rash</p><p><b>Postmarketing reports</b>: Vesicles at injection site, wheal and flare at injection site<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fever equal to or greater than 38C (rectal) or 37.5C (axillary/oral)</p><p><b>Common</b> (1% to 10%): Fever over 39.5C (rectal) or 39C (axillary/oral)</p><p><b>Uncommon</b> (0.1% to 1%): Otitis media, injury</p><p><b>Rare</b> (less than 0.1%): Death from various and in some cases unknown causes</p><p><b>Postmarketing reports</b>: Malaise, peripheral edema, papillitis, swelling, tenderness<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Uncommon</b> (0.1% to 1%): Dizziness</p><p><b>Rare</b> (less than 0.1%): Febrile convulsions</p><p><b>Postmarketing reports</b>: Encephalitis, cerebellitis, cerebellitis like symptoms (including transient gait disturbance and transient ataxia), Guillain-Barre syndrome, transverse myelitis, peripheral neuritis, subacute sclerosing panencephalitis, afebrile convulsions or seizures, encephalopathy, measles inclusion body encephalitis, paresthesia, polyneuritis, polyneuropathy, optic neuritis, retrobulbar neuritis, syncope<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, pharyngitis, bronchitis, cough, respiratory disorder, rhinitis</p><p><b>Uncommon</b> (0.1% to 1%): Nasopharyngitis, rhinorrhea, laryngitis, stridor, epistaxis, sinusitis</p><p><b>Rare</b> (less than 0.1%): Pneumonia, pneumonitis</p><p><b>Postmarketing reports</b>: Bronchial spasm, sore throat<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Urticaria, dermatitis, eczema, pruritus, herpes simplex, herpes zoster, skin exfoliation, nail disorder</p><p><b>Frequency not reported</b>: Panniculitis</p><p><b>Postmarketing reports</b>: Erythema multiforme, panniculitis, purpura, skin induration, Stevens-Johnson syndrome, pruritus<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Nervousness</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal crying, insomnia</p><p><b>Postmarketing reports</b>: Irritability<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea</p><p><b>Uncommon</b> (0.1% to 1%): Parotid gland enlargement, vomiting, gastrointestinal disorder, toothache, enteritis, gastroenteritis, stomatitis, stomatitis aphthous, abdominal pain</p><p><b>Rare</b> (less than 0.1%): Nausea</p><p><b>Frequency not reported</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lymphadenopathy, anemia</p><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, thrombocytopenic purpura</p><p><b>Frequency not reported</b>: Leukocytosis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Viral infection</p><p><b>Frequency not reported</b>: Atypical measles</p><p><b>Postmarketing reports</b>: Meningitis, measles-like syndrome, mumps-like syndrome (including orchitis, epididymitis, and parotitis)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Conjunctivitis</p><p><b>Postmarketing reports</b>: Ocular palsies, retinitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia</p><p><b>Frequency not reported</b>: Diabetes mellitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions</p><p><b>Postmarketing reports</b>: Anaphylactic reactions (including related phenomenon such as angioneurotic edema, facial edema, and peripheral edema), anaphylactoid reaction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (less than 0.1%): Vasculitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Epididymitis, orchitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Arthralgia, arthritis, myalgia<sup>[Ref]</sup></p><p>The vaccine has rarely been associated with chronic joint symptoms.  The incidence of arthritis and arthralgia is generally higher in adult women than in children (women, 12% to 26%; children, 0% to 3%), and symptoms tend to be more marked and of longer duration, persisting for months or years (rare).  In adolescent girls, the incidence of reactions appears to be intermediate between those seen in children and in women.  These reactions are generally well tolerated and rarely interfere with normal activities, even in women over 35 years old.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. M-M-R II (measles/mumps/rubella virus vaccine)." Merck &amp; Company Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about measles virus vaccine / mumps virus vaccine / rubella virus vaccine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: vaccine combinations</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Mumps Prophylaxis</li>
<li>Measles Prophylaxis</li>
<li>Rubella Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>